Atlas Trials

Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803

Clinical trial NCT02890758 · COMPLETED

Trial details

NCT number
NCT02890758
Sponsor
Brenda Cooper, MD
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Acute Myeloid LeukemiaMyelodysplastic SyndromeAcute Lymphoblastic LeukemiaChronic Myeloid LeukemiaChronic Lymphocytic LeukemiaNon Hodgkin LymphomaHodgkin LymphomaMyeloproliferative SyndromesPlasma Cell MyelomaColon CarcinomaAdenocarcinoma of RectumSoft Tissue Sarcoma
Start date
2018-05-22
Primary completion
2021-06-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.